Quote:
Originally Posted by Red Herring
There is actually logical argument behind the proposal, not just political gain.
In trials the Pfizer vaccine was found to be 90% effective after the first dose and this improved to 94% after the second.
So given it takes the same amount of clinical time to administer each dose would you rather have a number of people protected to 94%, or twice as many protected to only 90%?
I'd suggest at those odds it might be worth considering......
|
Seeing as this first lot is for the most vulnerable, the more the better IMO. These are the people you're trying to protect the most, you need to minimise the risk as much as possible and have the option to do so.
If it was a general one for all, then i'd say 90% is probably enough.